These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antimycobacterial activities of dehydrocostus lactone and its oxidation products. Cantrell CL; Nuñez IS; Castañeda-Acosta J; Foroozesh M; Fronczek FR; Fischer NH; Franzblau SG J Nat Prod; 1998 Oct; 61(10):1181-6. PubMed ID: 9784148 [TBL] [Abstract][Full Text] [Related]
3. Antimycobacterial activity of natural and semi-synthetic lignans. Silva ML; Martins CH; Lucarini R; Sato DN; Pavanb FR; Freitas NH; Andrade LN; Pereira AC; Bianco TN; Vinholis AH; Cunha WR; Bastos JK; Silva R; Da Silva Filho AA Z Naturforsch C J Biosci; 2009; 64(11-12):779-84. PubMed ID: 20158145 [TBL] [Abstract][Full Text] [Related]
4. Assessment of antimycobacterial activity of a series of mainly marine derived natural products. König GM; Wright AD; Franzblau SG Planta Med; 2000 May; 66(4):337-42. PubMed ID: 10865450 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives. Seitz LE; Suling WJ; Reynolds RC J Med Chem; 2002 Dec; 45(25):5604-6. PubMed ID: 12459027 [TBL] [Abstract][Full Text] [Related]
6. Antimycobacterial activity of 1-deaza-7,8-dihydropteridine derivatives against Mycobacterium tuberculosis and Mycobacterium avium complex in vitro. Suling WJ; Maddry JA J Antimicrob Chemother; 2001 Apr; 47(4):451-4. PubMed ID: 11266419 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimycobacterial activity of some N1-[1-[3-aryl-1-(pyridin-2-, 3-, or 4-yl)-3-oxo]propyl]-2- pyridinecarboxamidrazones. Mamolo MG; Falagiani V; Vio L; Banfi E Farmaco; 1999; 54(11-12):761-7. PubMed ID: 10668176 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and antimycobacterial activity of 1,2,4-triazole 3-benzylsulfanyl derivatives. Klimesová V; Zahajská L; Waisser K; Kaustová J; Möllmann U Farmaco; 2004 Apr; 59(4):279-88. PubMed ID: 15081345 [TBL] [Abstract][Full Text] [Related]
9. Heterocyclic benzazole derivatives with antimycobacterial in vitro activity. Kocí J; Klimesová V; Waisser K; Kaustová J; Dahse HM; Möllmann U Bioorg Med Chem Lett; 2002 Nov; 12(22):3275-8. PubMed ID: 12392731 [TBL] [Abstract][Full Text] [Related]
10. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates. Foroumadi A; Soltani F Boll Chim Farm; 2003; 142(6):248-50. PubMed ID: 14606264 [TBL] [Abstract][Full Text] [Related]
12. Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity. Barbachyn MR; Hutchinson DK; Brickner SJ; Cynamon MH; Kilburn JO; Klemens SP; Glickman SE; Grega KC; Hendges SK; Toops DS; Ford CW; Zurenko GE J Med Chem; 1996 Feb; 39(3):680-5. PubMed ID: 8576910 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides. Rai D; Johar M; Srivastav NC; Manning T; Agrawal B; Kunimoto DY; Kumar R J Med Chem; 2007 Sep; 50(19):4766-74. PubMed ID: 17696514 [TBL] [Abstract][Full Text] [Related]
14. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains]. Thomas L; Naumann P; Crea A Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424 [TBL] [Abstract][Full Text] [Related]